Correction
Accepted on 09 Jul 2025
Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm
in Multiple Sclerosis and Neuroimmunology
Correction
Accepted on 09 Jul 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 07 Jul 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 04 Jul 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 03 Jul 2025
in Multiple Sclerosis and Neuroimmunology
Editorial
Published on 03 Jul 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 01 Jul 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 01 Jul 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 30 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 30 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 30 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 26 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Review
Published on 26 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 20 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Review
Published on 19 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 18 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Mini Review
Published on 16 Jun 2025
in Multiple Sclerosis and Neuroimmunology